Syra Health Statistics
Total Valuation
Syra Health has a market cap or net worth of $4.64 million. The enterprise value is $2.97 million.
Important Dates
The last earnings date was Tuesday, March 11, 2025, before market open.
| Earnings Date | Mar 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Syra Health has 17.31 million shares outstanding. The number of shares has increased by 54.81% in one year.
| Current Share Class | 11.31M |
| Shares Outstanding | 17.31M |
| Shares Change (YoY) | +54.81% |
| Shares Change (QoQ) | +35.43% |
| Owned by Insiders (%) | 37.99% |
| Owned by Institutions (%) | 3.22% |
| Float | 8.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.27 |
| Forward PS | n/a |
| PB Ratio | 1.71 |
| P/TBV Ratio | 1.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.46, with a Debt / Equity ratio of 0.16.
| Current Ratio | 5.46 |
| Quick Ratio | 5.01 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -241.34 |
Financial Efficiency
Return on equity (ROE) is -109.09% and return on invested capital (ROIC) is -61.99%.
| Return on Equity (ROE) | -109.09% |
| Return on Assets (ROA) | -54.71% |
| Return on Invested Capital (ROIC) | -61.99% |
| Return on Capital Employed (ROCE) | -122.80% |
| Revenue Per Employee | $84,916 |
| Profits Per Employee | -$39,992 |
| Employee Count | 94 |
| Asset Turnover | 1.86 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.84% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -77.84% |
| 50-Day Moving Average | 0.40 |
| 200-Day Moving Average | 0.69 |
| Relative Strength Index (RSI) | 29.78 |
| Average Volume (20 Days) | 231,555 |
Short Selling Information
The latest short interest is 728,237, so 4.21% of the outstanding shares have been sold short.
| Short Interest | 728,237 |
| Short Previous Month | 870,670 |
| Short % of Shares Out | 4.21% |
| Short % of Float | 8.24% |
| Short Ratio (days to cover) | 1.21 |
Income Statement
In the last 12 months, Syra Health had revenue of $7.98 million and -$3.76 million in losses. Loss per share was -$0.50.
| Revenue | 7.98M |
| Gross Profit | 1.65M |
| Operating Income | -3.76M |
| Pretax Income | -4.19M |
| Net Income | -3.76M |
| EBITDA | -3.70M |
| EBIT | -3.76M |
| Loss Per Share | -$0.50 |
Full Income StatementBalance Sheet
The company has $2.40 million in cash and $452,077 in debt, giving a net cash position of $1.94 million or $0.11 per share.
| Cash & Cash Equivalents | 2.40M |
| Total Debt | 452,077 |
| Net Cash | 1.94M |
| Net Cash Per Share | $0.11 |
| Equity (Book Value) | 2.88M |
| Book Value Per Share | 0.17 |
| Working Capital | 2.74M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$2.93 million and capital expenditures -$11,111, giving a free cash flow of -$2.94 million.
| Operating Cash Flow | -2.93M |
| Capital Expenditures | -11,111 |
| Free Cash Flow | -2.94M |
| FCF Per Share | -$0.17 |
Full Cash Flow StatementMargins
Gross margin is 20.71%, with operating and profit margins of -47.17% and -47.10%.
| Gross Margin | 20.71% |
| Operating Margin | -47.17% |
| Pretax Margin | -47.10% |
| Profit Margin | -47.10% |
| EBITDA Margin | -46.38% |
| EBIT Margin | -47.17% |
| FCF Margin | n/a |